Clinical and Experimental Metastasis

SJR Rank #3,703H-index: 114SJR: 1.187Best quartile: Q1APC: US$5,090
Journal website: aims, scope and author guidelines
Publisher

Springer Science and Business Media B.V.

Country

Netherlands

Type

journal

SJR by Edition

2022202500.30.60.91.2

Subject Categories

  • Medicine (miscellaneous)Q1
  • Cancer ResearchQ2
  • OncologyQ2

Areas: Biochemistry, Genetics and Molecular Biology · Medicine

Most published research topics

Cancer Cells and MetastasisCell Adhesion Molecules ResearchProtease and Inhibitor MechanismsPeptidase Inhibition and AnalysisCancer Research and TreatmentsCancer Genomics and DiagnosticsImmunotherapy and Immune ResponsesCancer, Hypoxia, and MetabolismAngiogenesis and VEGF in CancerBone health and treatments

Source: OpenAlex

Publication Statistics

2025 Docs3-Year DocsCitable Docs050100150200

Documents per Year

20222025020406080

Detailed Information

ISSN

0262-0898, 1573-7276

SJR Best Quartile

Q1

Region

Western Europe

Citations per Document (2 years)

3.40

References per Document

58.79

Coverage

1983-2026

Scope

The Journal's scope encompasses all aspects of metastasis research, whether laboratory-based, experimental or clinical and therapeutic. It covers such areas as molecular biology, pharmacology, tumor biology, and clinical cancer treatment (with all its subdivisions of surgery, chemotherapy and radio-therapy as well as pathology and epidemiology) insofar as these disciplines are concerned with the Journal's core subject of metastasis formation, prevention and treatment.

Metrics from SCImago Journal Rank 2025. View on SCImago